Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20181001003
TCTR20181001003
Recruiting
未知

Population pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin after intravenous administration in pediatric patients

Graduate School, Chiang Mai University0 sites60 target enrollmentOctober 1, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsmultidrug resistant gram negative bacteria (MDR GNB)intravenous colistinPopulation pharmacokineticscolistimethate sodium (CMS)colistinintravenouspediatric patients

Overview

Phase
未知
Intervention
Not specified
Conditions
multidrug resistant gram negative bacteria (MDR GNB)intravenous colistin
Sponsor
Graduate School, Chiang Mai University
Enrollment
60
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 1, 2018
End Date
June 30, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Graduate School, Chiang Mai University

Eligibility Criteria

Inclusion Criteria

  • •1\. Age 1 †\<18 years old
  • •2\. Having indication for the use of IV colistin treatment
  • •3\. Having a stable renal function during 1 week before the initiation of IV
  • •colistin treatment

Exclusion Criteria

  • •1\. Hypersensitive to colistin or any component of the formulation
  • •2\. During pregnancy or breastfeeding
  • •3\. Had received or will receive renal replacement therapy
  • •4\. Diagnosed as having cystic fibrosis
  • •5\. Having obesity (%weight\-for\-height \>140\)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Population pharmacokinetics and pharmacodynamics of sorafenib in hepatocellular carcinoma patients with Child Pugh B liver cirrhosishepatocellular carcinomaliver cancer1001965410019815
NL-OMON44524Academisch Medisch Centrum45
Completed
Not Applicable
Study about the relationship between ramosetron dose, plasma concentration and antiemetic effectNot Applicable
KCT0001500Asan Medical Center51
Recruiting
Not Applicable
study for optimizing appropriate dosage of Caffeine and Aminophylline in premature new born babies with pause of breathing lasting atleast for 20 secondsHealth Condition 1: null- Premature neonates with apnea of prematurityHealth Condition 2: P073- Preterm [premature] newborn [other]
CTRI/2017/10/010132Science and Engineering Research Board
Recruiting
Phase 2
Setting of appropriate dosage and comparing the effectiveness of Caffeine and Aminophylline in premature babies with pause of breathing for 15 to 20 seconds
CTRI/2015/06/005904Kasturba Medical College402
Recruiting
Not Applicable
Population pharmacokinetic and pharmacodynamic modeling of propofol in underweight patients under general anesthesiaNot Applicable
KCT0001760Asan Medical Center20